Biotech

All Articles

A more detailed examine Intense Biotech's Intense 15

.In this particular week's incident of "The Top Pipe," our experts are actually diving right into Br...

Lilly experiences stage 2 failure of tau-targeting med

.The confetti is actually still flying from Eli Lilly's party commemorating the approval of Alzheime...

Biogen CMO Maha Radhakrishnan joins Sofinnova-- Chutes &amp Ladders

.Accept to today's Chutes &amp Ladders, our roundup of notable management hirings, firings and also ...

Lykos will talk to FDA to reevaluate its decision adhering to rejection of MDMA treatment for post-traumatic stress disorder

.Observing a poor revealing for Lykos Therapeutics' MDMA prospect for post-traumatic stress disorder...

AN 2 one-halfs headcount, stops period 3 trial after data let down

.AN2 Therapies is reconsidering its own business in response to uninspired midphase records, swearin...

Merck pays out $700M for bispecific, spying autoimmune position and also chance to test Amgen in cancer cells

.Merck &amp Co. is actually paying $700 thousand upfront to test Amgen in a blood stream cancer cell...

Gilead pays J&ampJ $320M to exit licensing bargain for seladelpar

.With Gilead Sciences about to an FDA decision for its liver condition medicine seladelpar, the firm...

' All hands on deck' at Lilly as peers target being overweight market

.CEO David Ricks can see the business establishing camping tents at basecamp behind Eli Lilly in an ...

Entero giving up workers, moving out of workplace and pausing R&ampD

.Cushion Liquidators has transformed Entero Therapies white colored as a slab. The financial institu...

Exelixis drops ADC after choosing it is actually no match for Tivdak

.Exelixis is actually surrendering on its tissue factor (TF)- targeting antibody-drug conjugate afte...